Skip to main content
. 2018 Nov;6(22):444. doi: 10.21037/atm.2018.10.24

Figure 3.

Figure 3

Radiographical changes of the patient in case 1 during the pembrolizumab treatment (A) after treatment with erlotinib, CT scan showed a greater increase in the size of tumor in the right upper lobe and mediastinal lymphadenopathy, compared with the size shown in the initial CT scan; (B) twenty-one days after beginning pembrolizumab treatment, CT scan showed a reduced tumor size in the primary lesion of the right lung. CT, computed tomography.